| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-11 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-11 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-11 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-11 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-11 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-11 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.32 | 9e-11 |